Inicio>>Signaling Pathways>> Apoptosis>>Pitstop2

Pitstop2

Catalog No.GC45549

Pitstop2 es un inhibidor selectivo de la endocitosis mediada por clatrina (CME).

Products are for research use only. Not for human use. We do not sell to patients.

Pitstop2 Chemical Structure

Cas No.: 1419320-73-2

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
580,00 $
Disponible
2mg
32,00 $
Disponible
5mg
49,00 $
Disponible
10mg
89,00 $
Disponible
25mg
177,00 $
Disponible
50mg
280,00 $
Disponible
100mg
456,00 $
Disponible
200mg
671,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Pitstop2 is an inhibitor of the interaction between the clathrin terminal domain and amphiphysin (IC50 = 12 μM).1 It inhibits clathrin-mediated transferrin uptake in HeLa and U2OS cells (IC50s = 12-15 and 9.7 μM, respectively). Pitstop2 inhibits HIV-1 entry and infectivity in HeLa reporter cell lines. It also inhibits clathrin-independent endocytosis of CD44, CD98, and CD147 in HeLa cells.2

References
1. von Kleist, L., Stahlschmidt, W., Bulut, H., et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146(3), 471-484 (2012).
2. Dutta, D., Williamson, C.D., Cole, N.B., et al. Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS One 7(9), e45799 (2012).

Reseñas

Review for Pitstop2

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pitstop2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.